Possis Medical Adds New Thrombectomy Catheter To The Spiroflex Family Product Line

Minneapolis - Possis Medical, Inc. announced market release of the AngioJet Spiroflex VG Rheolytic Thrombectomy catheter.

The new Spiroflex VG Catheter provides over twice the clot removing power compared to the Company's 4 French XMI and Spiroflex catheters and it is the first AngioJet catheter of its size to be offered in a Rapid Exchange platform.

Utilizing its proprietary Spiroflex shaft technology, the Spiroflex VG catheter benefits from several design improvements made to the most recent generation of Possis Medical products. This new catheter offers improved trackability inside the vessel and includes tip and hub improvements found on the recently introduced Spiroflex catheter.

"Our Cross-Stream technology and the flexibility of our proprietary drive unit allow us to design and deliver thrombectomy catheters specifically tailored to the needs expressed by physicians," said Robert G. Dutcher, Chairman, President and CEO of Possis Medical. "Our growing catalog of endovascular tools is based on our experience as the industry leader in mechanical thrombectomy and on the valuable information and guidance we receive from our customers. The new Spiroflex VG catheter is one more example of our ability to provide powerful, technologically advanced therapies in response to the needs of our market," said Dutcher.

The Spiroflex VG Catheter is now fully released for sale in the U.S. for peripheral use and the Company will submit for coronary approval in the U.S. in coming weeks. International CE mark approval for coronary and peripheral use is pending.

SOURCE: Possis Medical Inc.